Ionis’ Tryngolza ‘Game-Changing in Lowering Triglycerides, Cementing Case for FDA Filing
Ionis is planning a supplemental submission by the end of the year to expand Tryngolza into severe hypertriglyceridemia. If granted, William Blair expects the antisense drug to be “transformational” for this indication.
Ionis’ Tryngolza ‘Game-Changing in Lowering Triglycerides, Cementing Case for FDA Filing Read More »
